stroke

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

In Wine There Is Truth

By: Katharine Cimmino, Editor-in-Chief - Many articles and quick one-line stories have been cropping up on the internet boasting the…

12 years ago

Reservoir of Migraine Therapies Includes Analgesics, AEDs, and now Monoclonal Antibodies

By Davidta Brown, Senior Staff Editor - The pain, nausea, and light or sound sensitivity that comprise a migraine attack…

12 years ago

Quantifying the Benefits of Pharmacist Prescribing Power

By Davidta Brown, Senior Staff Editor - The idea of granting pharmacists the right to prescribe, as well as to…

12 years ago

Antipsychotic Use in the Elderly with Dementia

By: Ada Seldin, Staff Editor - The overuse of antipsychotics in the nursing home population for off-label indications continues to…

12 years ago

New Considerations for Testosterone Therapy

By: Jenny Park PharmD Candidate c/o 2015 - Testosterone is a hormone essential to male development. However, treatment of testosterone…

12 years ago

The Surgeon General’s 2014 Report on Smoking

By: Ada Seldin, Staff Editor - Since the first release of the Surgeon General’s Report on smoking 50 years ago,…

12 years ago

A Brave New World for Lipid Management

By: Amrita Singh, PharmD Candidate c/o 2015 - Last November, the American College of Cardiology and the American Heart Association…

12 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Calcium Intake and Risk of Myocardial Infarction

By:  Lila Ahmed, PharmD Candidate c/o 2013 - In the past, numerous research efforts have attempted to prove the benefits…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Antiplatelet Use Following Acute Coronary Syndromes

By: Addolorata Ciccone, Co-Copy Editor - Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction…

14 years ago

Lipid Panels: Fasting or Non-Fasting?

By: Nagma Gargi, Pharm D. Candidate 2013 - Traditionally, lipid panels are drawn under fasting conditions. Is there data supporting…

14 years ago

Brilinta® vs. Plavix® in Patients with Acute Coronary Syndromes

By: Ronik Saha, Pharm.D. Candidate c/o 2013 - Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

FDA Approves Edarbyclor®

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 - Hypertension is a chronic disease that affects one out of every three…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago

Clinical Update: Heart Failure and Osteoporosis-Related Fractures

By: Mahdieh Danesh Yazdi - Heart failure is a condition in which the heart cannot pump blood efficiently to adequately…

15 years ago